Tim Brighton

1.1k total citations
22 papers, 866 citations indexed

About

Tim Brighton is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tim Brighton has authored 22 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Internal Medicine and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tim Brighton's work include Venous Thromboembolism Diagnosis and Management (11 papers), Platelet Disorders and Treatments (9 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Tim Brighton is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Platelet Disorders and Treatments (9 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Tim Brighton collaborates with scholars based in Australia, New Zealand and United States. Tim Brighton's co-authors include B Murray, BH Chong, CN Chesterman, Huyen Tran, Sanjeev Chunilal, Simon McRae, Roger M. Lyons, Michael J. Kovacs, Bruce L. Davidson and Jan Beyer‐Westendorf and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Drugs.

In The Last Decade

Tim Brighton

21 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Brighton Australia 13 451 367 366 184 108 22 866
Tim Nokes United Kingdom 15 456 1.0× 325 0.9× 499 1.4× 200 1.1× 41 0.4× 29 1.0k
Suman L. Sood United States 16 215 0.5× 200 0.5× 375 1.0× 115 0.6× 34 0.3× 52 871
Maria Teresa Sartori Italy 22 308 0.7× 135 0.4× 499 1.4× 278 1.5× 45 0.4× 59 1.2k
Z Boda Hungary 19 716 1.6× 608 1.7× 863 2.4× 383 2.1× 133 1.2× 81 1.6k
Mario Bazzan Italy 16 334 0.7× 167 0.5× 230 0.6× 110 0.6× 233 2.2× 30 743
Mandy N. Lauw Netherlands 14 327 0.7× 420 1.1× 202 0.6× 62 0.3× 27 0.3× 38 908
Raskob Ge United States 6 463 1.0× 250 0.7× 902 2.5× 266 1.4× 98 0.9× 9 1.4k
Frederick A. Meyers United States 11 603 1.3× 342 0.9× 257 0.7× 137 0.7× 188 1.7× 11 905
L. Pinède France 16 682 1.5× 1.1k 2.9× 254 0.7× 722 3.9× 118 1.1× 44 1.9k
A Girolami Italy 20 319 0.7× 217 0.6× 894 2.4× 268 1.5× 59 0.5× 120 1.4k

Countries citing papers authored by Tim Brighton

Since Specialization
Citations

This map shows the geographic impact of Tim Brighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Brighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Brighton more than expected).

Fields of papers citing papers by Tim Brighton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Brighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Brighton. The network helps show where Tim Brighton may publish in the future.

Co-authorship network of co-authors of Tim Brighton

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Brighton. A scholar is included among the top collaborators of Tim Brighton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Brighton. Tim Brighton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chunilal, Sanjeev, Vivien Chen, Tim Brighton, et al.. (2021). The first known case of vaccine‐induced thrombotic thrombocytopenia in Australia. The Medical Journal of Australia. 215(1). 19–19. 20 indexed citations
2.
Chunilal, Sanjeev, Vivien Chen, Tim Brighton, et al.. (2021). The first known ChAdOx1 nCoV-19 vaccine-induced thrombotic thrombocytopenia in Australia. The Medical Journal of Australia. 1. 1 indexed citations
3.
Merriman, Eileen, Sanjeev Chunilal, Tim Brighton, et al.. (2021). Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study). Thrombosis Research. 207. 33–39. 4 indexed citations
4.
Matthews, Gail, et al.. (2016). Cytomegalovirus‐associated thrombocytopenia treated with thrombopoietin receptor agonist. Internal Medicine Journal. 46(9). 1096–1099. 5 indexed citations
5.
6.
7.
Brighton, Tim, et al.. (2013). Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. Journal of Vascular Surgery. 57(3). 892–892. 4 indexed citations
8.
McLintock, Claire, Tim Brighton, Sanjeev Chunilal, et al.. (2013). Recommendations for the Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism in Pregnancy and the Postpartum Period. Obstetric Anesthesia Digest. 33(1). 14–15. 2 indexed citations
9.
Malhotra, Abhishek, et al.. (2012). Platelet Function and Constituents of Platelet Rich Plasma. International Journal of Sports Medicine. 34(1). 74–80. 25 indexed citations
10.
McLintock, Claire, Tim Brighton, Sanjeev Chunilal, et al.. (2011). Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period. Australian and New Zealand Journal of Obstetrics and Gynaecology. 52(1). 14–22. 81 indexed citations
11.
McLintock, Claire, Tim Brighton, Sanjeev Chunilal, et al.. (2011). Recommendations for the prevention of pregnancy‐associated venous thromboembolism. Australian and New Zealand Journal of Obstetrics and Gynaecology. 52(1). 3–13. 63 indexed citations
12.
Nourse, Jamie P., Rod A. Lea, Pauline Crooks, et al.. (2011). The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms. Blood Coagulation & Fibrinolysis. 23(1). 45–50. 17 indexed citations
13.
14.
Mallarkey, Gordon, et al.. (2008). An Evaluation of Eptacog Alfa in Nonhaemophiliac Conditions. Drugs. 68(12). 1665–1689. 11 indexed citations
15.
Brighton, Tim, et al.. (2007). Isolated thrombocytopenia in children: Thinking beyond idiopathic thrombocytopenic purpura and Leukaemia. Journal of Paediatrics and Child Health. 43(12). 848–850. 1 indexed citations
16.
Ho, Shir‐Jing & Tim Brighton. (2006). Ximelagatran, direct thrombin inhibitor, oral anticoagulants, thromboprophylaxis. Vascular Health and Risk Management. 2(1). 49–58. 29 indexed citations
17.
Chong, Beng H., et al.. (2005). Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis. Journal of Thrombosis and Thrombolysis. 19(3). 173–181. 39 indexed citations
18.
Craft, Judy, Paul P. Masci, Michael S. Roberts, et al.. (2004). Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients. Blood Coagulation & Fibrinolysis. 15(6). 475–482. 18 indexed citations
19.
Sheng, Yonghua, Stephen Reddel, Herbert Herzog, et al.. (2001). Impaired Thrombin Generation in β2-Glycoprotein I Null Mice. Journal of Biological Chemistry. 276(17). 13817–13821. 65 indexed citations
20.
Chong, BH, et al.. (1994). Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood. 83(6). 1535–1541. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Nokes Breakdown of academic impact, for papers by Suman L. Sood Breakdown of academic impact, for papers by Maria Teresa Sartori Breakdown of academic impact, for papers by Z Boda Breakdown of academic impact, for papers by Mario Bazzan Breakdown of academic impact, for papers by Mandy N. Lauw Breakdown of academic impact, for papers by Raskob Ge Breakdown of academic impact, for papers by Frederick A. Meyers Breakdown of academic impact, for papers by L. Pinède Breakdown of academic impact, for papers by A Girolami
Rankless by CCL
2026